Subscribe to RSS
DOI: 10.1055/s-0042-105215
Perkutane Phil™-Embolisation zur präoperativen Therapie von Karotis-Paragangliomen
Percutaneous Phil™-Embolization for Preoperative Therapy of Carotid Body ParagangliomasPublication History
eingereicht 14 February 2016
akzeptiert 14 March 2016
Publication Date:
29 June 2016 (online)
Zusammenfassung
Einleitung:Paragangliome sind seltene Tumore, welche eine therapeutische Herausforderung darstellen. Insbesondere die operative Entfernung kann zu lebensbedrohlichen Blutungen führen. Die präoperative perkutane Embolisation ist gegenüber der intraarteriellen Technik eine Alternative, die in kurzer Interventionszeit eine eine hohe Verschlussrate der tumorversorgenden Gefäße ermöglicht und damit entscheidend die intraoperative Blutungswahrscheinlichkeit reduziert. Die vollständige Tumorresektion wird dabei erleichtert. Der Einsatz eines neuen zugelassenen Flüssigembolisats wird hier vorgestellt.
Methoden: Im Klinikum Augsburg wurde eine 50-jährige Patientin mit 4 cm großen Paragangliom caroticum (Shamblin II) behandelt. Zunächst wurde eine perkutane Embolisation mit 7 ml PHIL™ (precipitating hydrophobic injectable liquid) durchgeführt. Nach 24 Stunden erfolgte die komplette operative Resektion des Tumors.
Ergebnisse: Eine gute Verteilung des flüssigen Embolisats über den gesamten Tumor konnte erzielt werden. Intraoperativ wurde die Resektion des Tumors aufgrund der geringen Blutungsneigung über die gesamte Tumoroberfläche deutlich erleichtert und beschleunigt. Der gesamte Blutverlust lag unter 50 ml. Alle benachbarten Nerven- und arteriellen Strukturen konnten geschont werden. Postoperativ zeigten sich keine Nervenfunktionsstörungen und die Patientin konnte am 4. postoperativen Tag entlassen werden.
Schlussfolgerung: Die Kombination aus perkutaner Embolisation und operativer Resektion bieten insbesondere für fortgeschrittene Paragangliome der Karotisbifurkation einen sicheren Therapieeinsatz. Die Verwendung eines neuen flüssigen Embolisats kann möglicherweise zukünftig die Therapie weiter optimieren.
Abstract
Introduction: Paragangliomas are rare tumors representing a therapeutic challenge. In particular, the surgical removal may lead to life-threatening bleeding. The preoperative percutaneous embolization is an alternative that allows a high closure rate of tumor-feeding vessels in a short intervention time and thus significantly reduces intraoperative bleeding probability. Complete tumor resection is facilitated thereby. The use of a new non-adhesive liquid embolic agent is presented here.
Methods: A 50-year old patient presented with 4 cm large paraganglioma of the carotid body (Shamblin II). A percutaneous embolization with 7 ml PHIL™ (injectable precipitating hydrophobic liquid) was performed preoperatively. 24 h later the complete surgical resection of the tumor was performed.
Results: A good distribution of the liquid embolic agent could be achieved over the entire tumor. Intraoperative resection of the tumor was much easier and faster due to low bleeding tendency over the entire surface of the tumor. Total blood loss was less than 50 ml. All adjacent nerve and arterial structures could be spared. Postoperative nerve function was normal and the patient was discharged on the 4th postoperative day.
Conclusion: The combination of percutaneous embolization and surgical resection provides a safe combination in the treatment of advanced carotid body paragangliomas. The use of a novel liquid embolic agent may possibly further optimize the therapy.
-
Literatur
- 1 Moore MG, Netterville JL, Mendenhall WM, Isaacson B, Nussenbaum B. Head and Neck Paragangliomas: An Update on Evaluation and Management. Otolaryngol Head Neck Surg 2016
- 2 Power AH, Bower TC, Kasperbauer J, Link MJ, Oderich G, Cloft H, Young Jr. WF, Gloviczki P. Impact of preoperative embolization on outcomes of carotid body tumor resections. J Vasc Surg 2012; 56: 979-989
- 3 Shamblin WR, ReMine WH, Sheps SG, Harrison Jr. EG. Carotid body tumor (chemodectoma). Clinicopathologic analysis of ninety cases. Am J Surg 1971; 122: 732-739
- 4 Bozzato A. Interpretation of ultrasound findings in otorhinolaryngology. Salivary glands, paraganglioma, angioma, esophagus, hypopharynx, extra cranial vessels and temporomandibular joint. HNO 2015; 63: 453-465 quiz 466-467
- 5 Neves F, Huwart L, Jourdan G, Reizine D, Herman P, Vicaut E, Guichard JP. Head and neck paragangliomas: value of contrast-enhanced 3D MR angiography. AJNR Am J Neuroradiol 2008; 29: 883-889
- 6 Janssen I, Chen CC, Taieb D, Patronas NJ, Millo CM, Adams KT, Nambuba J, Herscovitch P, Sadowski SM, Fojo AT, Buchmann I, Kebebew E, Pacak K. 68Ga-DOTATATE PET/CT in the Localization of Head and Neck Paragangliomas Compared with Other Functional Imaging Modalities and CT/MRI. J Nucl Med 2016; 57: 186-191
- 7 Kunzel J, Koch M, Brase C, Fietkau R, Iro H, Zenk J, Shamblin WR. Treatment of cervical paragangliomas: is surgery the only way?. Am J Otolaryngol 2014; 35: 186-191
- 8 Rangel-Castilla L, Shah AH, Klucznik RP, Diaz OM. Preoperative Onyx embolization of hypervascular head, neck, and spinal tumors: experience with 100 consecutive cases from a single tertiary center. J Neurointerv Surg 2014; 6: 51-56
- 9 Ulrich S, Lehmann M, Ebmeyer J, Hamberger U, Reineke U, Dietrich U, Sudhoff H. Direct percutaneous embolization of a carotid body tumor with Onyx. HNO 2009; 57: 1305-1310
- 10 Samaniego EA, Kalousek V, Abdo G, Ortega-Gutierrez S. Preliminary experience with Precipitating Hydrophobic Injectable Liquid (PHIL) in treating cerebral AVMs. J Neurointerv Surg 2016
- 11 Kunzel J, Bahr K, Hainz M, Rossmann H, Matthias C. Head and neck paragangliomas: An interdisciplinary challenge. HNO 2015; 63: 821-830
- 12 Capatina C, Ntali G, Karavitaki N, Grossman AB. The management of head-and-neck paragangliomas. Endocr Relat Cancer 2013; 20: R291-R305
- 13 Kunzel J, de Tristan J, Mantsopoulos K, Koch M, Baussmerth M, Zenk J, Iro H. Experiences in the treatment of patients with multiple head and neck paragangliomas. Am J Otolaryngol 2014; 35: 294-299
- 14 Amato B, Bianco T, Compagna R, Siano M, Esposito G, Buffone G, Serra R, de Franciscis S. Surgical resection of carotid body paragangliomas: 10 years of experience. Am J Surg 2014; 207: 293-298
- 15 Lim JY, Kim J, Kim SH, Lee S, Lim YC, Kim JW, Choi EC. Surgical treatment of carotid body paragangliomas: outcomes and complications according to the shamblin classification. Clin Exp Otorhinolaryngol 2010; 3: 91-95
- 16 Jackson RS, Myhill JA, Padhya TA, McCaffrey JC, McCaffrey TV, Mhaskar RS. The Effects of Preoperative Embolization on Carotid Body Paraganglioma Surgery: A Systematic Review and Meta-analysis. Otolaryngol Head Neck Surg 2015; 153: 943-950
- 17 Bercin S, Muderris T, Sevil E, Gul F, Kılıcarslan A, Kiris M. Efficiency of preoperative embolization of carotid body tumor. Auris Nasus Larynx 2015; 42: 226-230
- 18 Economopoulos KP, Tzani A, Reifsnyder T. Adjunct endovascular interventions in carotid body tumors. J Vasc Surg 2015; 61: 1081-1091 e2
- 19 Griauzde J, Gemmete JJ, Chaudhary N, Pandey AS, Sullivan SE, McKean EL, Marentette LJ. A comparison of particulate and Onyx embolization in preoperative devascularization of carotid body tumors. Neuroradiology 2013; 55: 1113-1118
- 20 Zhang TH, Jiang WL, Li B, Yamakawa T, Shamblin WR. Perioperative approach in the surgical management of carotid body tumors. Ann Vasc Surg 2012; 26: 775-782
- 21 Berenstein A. Treatment of experimental aneurysms with a new liquid embolic agent and a retrievable stent: proof of concept and feasibility study. J Neurointerv Surg 2015